CELLULAR BIOMEDICINE GROUP news, videos and press releases
For more news please use our advanced search feature.
CELLULAR BIOMEDICINE GROUP - More news...
CELLULAR BIOMEDICINE GROUP - More news...
- Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer
- Cellular Biomedicine Group, Inc. Announces Completion of Merger
- Cellular Biomedicine Group, Inc. Stockholders Approve Merger
- Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
- Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting
- Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited
- Wolf Popper LLP Investigates the Proposed Acquisition of Cellular Biomedicine Group, Inc. by a Controlling Shareholder Consortium
- Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)
- Cellular Biomedicine Group to Present at Chinese Biopharmaceutical Association-USA Annual Conference
- CELLULAR BIOMEDICINE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cellular Biomedicine Group, Inc. - CBMG
- CMBG INVESTIGATION: Shareholder Rights Firm Labaton Sucharow is Investigating Cellular Biomedicine Group, Inc. (NASDAQ: CMBG) for Potential Securities Violations and Breach of Fiduciary Duty
- Kaskela Law LLC Announces Investigation of Cellular Biomedicine Group, Inc. (CBMG) and Encourages CBMG Shareholders to Contact the Firm
- ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cellular Biomedicine Group, Inc.
- INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Cellular Biomedicine Group, Inc. - CBMG
- SHAREHOLDER ALERT: WeissLaw LLP Investigates Cellular Biomedicine Group, Inc.
- CELLULAR BIOMEDICINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CBMG and Encourages Investors to Contact the Firm
- Cellular Biomedicine Group (CBMG) Reports Q2, H1 2020 Financial Results and Business Highlights
- Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private
- Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical Programs
- Cellular Biomedicine Group (CBMG) to Host Investor R&D Showcase Highlighting Updates to Clinical Programs
- Cellular Biomedicine Group (CBMG) Announces Results of 2020 Annual Meeting of Stockholders
- Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual Meeting
- Cellular Biomedicine Group (CBMG) Announces 2020 Annual Meeting of Stockholders
- Cellular Biomedicine Group Reports Q1 2020 Financial Results and Business Highlights
- Cellular Biomedicine Group to Report First Quarter 2020 Results on May 6, 2020
- Cellular Biomedicine Group Announces Q4 and Full Year 2019 Financial Results and Recent Operational Progress
- Cellular Biomedicine Group to Report Fourth Quarter and Full Year 2019 Results on February 28, 2020
- Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee
- Cellular Biomedicine Group Presents First Clinical Data of IIT Phase 1 Trial of C-CAR088, a Novel BCMA CAR-T, at the 61st Annual Meeting of the American Society of Hematology
